In a letter dated Sept. 30, the agency approved an additional generic version of the abortion drug mifepristone, this one by ...
Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback